Pregnancy in myositis and scleroderma

Sirajum Munira, Lisa Christopher-Stine

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Myositis and scleroderma are both rare autoimmune diseases with female predominance and often occur before and during reproductive years. The rarity of diseases explains the low frequency of concurrent disease and pregnancy. Like other autoimmune diseases, myositis and scleroderma may be more active during pregnancy as well. To date, many patients with myositis and scleroderma can have favorable pregnancy outcomes with careful management. This chapter provides a current overview of pregnancy outcomes in myositis and scleroderma. A major theme that appears to have emerged across these inflammatory diseases is that active maternal disease during pregnancy is associated with adverse pregnancy outcomes, and thus, personalized management is necessary depending on the disease state and comorbidities.

Original languageEnglish (US)
Pages (from-to)59-67
Number of pages9
JournalBest Practice and Research: Clinical Obstetrics and Gynaecology
StatePublished - Apr 2020


  • Idiopathic inflammatory myopathies
  • Myositis
  • Pregnancy
  • Reproductive health
  • Scleroderma

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Pregnancy in myositis and scleroderma'. Together they form a unique fingerprint.

Cite this